Showing results (41-50 of 48) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Haematologica|February 5, 2026
Multicenter prospective phase II study of decitabine priming with low-dose idarubicin, cytarabine, and G-CSF in children with refractory or relapsed acute myeloid leukemiaLiyan Fan, Li Gao, Weina Zhang, et al.Blood|March 11, 2026
A low- versus standard-dose regimen as induction for pediatric AML: a multicenter, randomized noninferiority trialLi Gao, Xiaowen Zhai, Ningling Wang, et al.The Oncologist|June 29, 2026
Comparison of Allo-HSCT outcomes after CAR-T therapy versus chemotherapy in pediatric patients with relapsed/refractory B-ALL: a retrospective studyBohan Li, Chengjuan Luo, Jun Lu, et al.Leukemia|November 24, 2023
Prognostic implications of CD9 in childhood acute lymphoblastic leukemia: insights from a nationwide multicenter study in ChinaKam Tong Leung, Jiaoyang Cai, Yu Liu, et al.Cell & Bioscience|April 13, 2025
The RBM39 degrader indisulam inhibits acute megakaryoblastic leukemia by altering the alternative splicing of ZMYND8Ying Yang, Zhiheng Li, Yang Yang, et al.Blood|January 9, 2025
Prognostic and therapeutic implications of measurable residual disease levels during remission induction of childhood ALLWeina Zhang, Jiaoyang Cai, Xiang Wang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 8, 2022
Coadministration of CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell Acute Lymphoblastic Leukemia: A Single-Arm, Multicenter, Phase II TrialTianyi Wang, Yanjing Tang, Jiaoyang Cai, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2021
Arsenic Combined With All-Trans Retinoic Acid for Pediatric Acute Promyelocytic Leukemia: Report From the CCLG-APL2016 Protocol StudyHuyong Zheng, Hui Jiang, Shaoyan Hu, et al.Pageof 5